Gene · 5600
Papers1,936
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 1,936
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Novel kinase regulators of extracellular matrix internalisation identified by high-content screening modulate invasive carcinoma cell migration. | PLoS Biol | 2024 | 39666682 | PubTator, text mining | PubMed |
| Proteomic analysis of the combined effects of cannabigerol and 3-O-ethyl ascorbic acid on kinase-dependent signalling in UVB-irradiated human keratinocytes. | Sci Rep | 2024 | 39537961 | PubTator, text mining | PubMed |
| Transcriptome analysis of the cytokine storm-related genes among the subtypes of idiopathic multicentric Castleman disease. | J Clin Exp Hematop | 2024 | 39462545 | PubTator, text mining | PubMed |
| Clean-label alternatives for food preservation: An emerging trend. | Heliyon | 2024 | 39247286 | PubTator, text mining | PubMed |
| ANXA5 predicts prognosis and immune response and mediates proliferation and migration in head and neck squamous cell carcinoma. | Gene | 2024 | 39168258 | PubTator, text mining | PubMed |
| The Invasion Factor ODZ1 Is Upregulated through an Epidermal Growth Factor Receptor-Induced Pathway in Primary Glioblastoma Cells. | Cells | 2024 | 38727302 | PubTator, text mining | PubMed |
| Pirfenidone ameliorates alcohol-induced promotion of breast cancer in mice. | Front Oncol | 2024 | 38590657 | PubTator, text mining | PubMed |
| TSPAN8+ myofibroblastic cancer-associated fibroblasts promote chemoresistance in patients with breast cancer. | Sci Transl Med | 2024 | 38569015 | PubTator, text mining | PubMed |
| Identification and preliminary analysis of hub genes associated with bladder cancer progression by comprehensive bioinformatics analysis. | Sci Rep | 2024 | 38307969 | PubTator, text mining | PubMed |
| Phosphorylation of human glioma-associated oncogene 1 on Ser937 regulates Sonic Hedgehog signaling in medulloblastoma. | Nat Commun | 2024 | 38307877 | PubTator, text mining | PubMed |
| Proline-directed yeast and human MAP kinases phosphorylate the Dot1p/DOT1L histone H3K79 methyltransferase. | FEBS J | 2024 | 38270553 | Swiss-Prot, curated | PubMed |
| Temporal Quantitative Proteomic and Phosphoproteomic Profiling of SH-SY5Y and IMR-32 Neuroblastoma Cells during All-Trans-Retinoic Acid-Induced Neuronal Differentiation. | Int J Mol Sci | 2024 | 38256121 | PubTator, text mining | PubMed |
| p38 Molecular Targeting for Next-Generation Multiple Myeloma Therapy. | Cancers (Basel) | 2024 | 38254747 | PubTator, text mining | PubMed |
| Unexpected inhibition of the lipid kinase PIKfyve reveals an epistatic role for p38 MAPKs in endolysosomal fission and volume control. | Cell Death Dis | 2024 | 38253602 | PubTator, text mining | PubMed |
| Transcriptomic characterization of the human segmental endotoxin challenge model. | Sci Rep | 2024 | 38242945 | PubTator, text mining | PubMed |
| Natural products targeting the MAPK-signaling pathway in cancer: overview. | J Cancer Res Clin Oncol | 2024 | 38193944 | PubTator, text mining | PubMed |
| Pathway-driven analysis of synthetic lethal interactions in cancer using perturbation screens. | Life Sci Alliance | 2024 | 37863651 | PubTator, text mining | PubMed |
| Current implications and challenges of artificial intelligence technologies in therapeutic intervention of colorectal cancer. | Explor Target Antitumor Ther | 2023 | 38213536 | PubTator, text mining | PubMed |
Efficacy and safety of regorafenib in combination with immune checkpoint inhibitor therapy as second-line and third-line regimen for patients with advanced hepatocellular carcinoma: a retrospective study. | J Gastrointest Oncol | 2023 | 38196523 | PubTator, text mining | PubMed |
| Comprehensive analysis of senescence-related genes and immune infiltration in intervertebral disc degeneration: a meta-data approach utilizing bulk and single-cell RNA sequencing data. | Front Mol Biosci | 2023 | 38187091 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5600/papers?page=3